News
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the U.S. Food and Drug Administration. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is approved for the early detection of amyloid plaques associated with Alzheimer disease in patients aged 55 years and older who are showing signs of the disease.
ATLANTA - Colon cancer is the ... Guardant recently released an FDA-approved test called Shield. It can detect signs of colorectal cancer with a simple draw of blood. "If my husband had ...
Teal Health said the FDA ... test had the same performance as clinician-collected samples. AP Egan pointed to another at-home test called Cologuard, made by Exact Sciences, to detect colon ...
Teal Health said the FDA's decision was ... Egan pointed to another at-home test called Cologuard, made by Exact Sciences (EXAS.O), opens new tab, to detect colon cancer. "So Cologuard (is ...
FDA OKs first blood test ... cancer Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can ...
If conducted every year or every other year, the multi-cancer early detection blood test could ... reliably detect cancer among those at high risk, including tests for breast, colon, ...
The Food and Drug Administration approved the first at-home test for cervical cancer screening in the US ... them to a certified lab for testing. The FDA’s decision to approve the test was ...
In a study conducted by the makers of the at-home cervical cancer test ... The US Food and Drug Administration (FDA) has approved the Teal Wand, an at-home test that screens for human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results